Stereotactic radiosurgery for brain metastases: evolving practice patterns from the national cancer database (2004–2020) - Takeaways - MDSpire

Stereotactic radiosurgery for brain metastases: evolving practice patterns from the national cancer database (2004–2020)

  • By

  • Jonathan J. Shih

  • Bhav Jain

  • Rohan Patel

  • Urvish Jain

  • Miranda Lam

  • Fumiko Chino

  • Manali I. Patel

  • Edward Christopher Dee

  • Erqi Pollom

  • Gordon Li

  • Kekoa Taparra

  • August 22, 2025

  • 0 min

Share

  • 1

    Over 200,000 cancer patients in the U.S. develop brain metastases annually, leading to significant mortality and morbidity.

  • 2

    Stereotactic radiosurgery (SRS) has emerged as a preferred treatment for limited brain metastases due to lower neurotoxicity compared to whole brain radiation therapy (WBRT).

  • 3

    Disparities in SRS utilization exist, influenced by socioeconomic factors, insurance coverage, and access to specialized care.

  • 4

    Patients from marginalized backgrounds are more likely to require WBRT and face treatment delays compared to those with better access to care.

  • 5

    This study analyzes trends in SRS versus WBRT utilization from 2004 to 2020, aiming to uncover disparities based on sociodemographic factors.

Original Source(s)

Stereotactic radiosurgery for brain metastases: evolving practice patterns from the national cancer database (2004–2020)

  • by Jonathan J. Shih, Bhav Jain, Rohan Patel, Urvish Jain, Miranda Lam, Fumiko Chino, Manali I. Patel, Edward Christopher Dee, Erqi Pollom, Gordon Li, Kekoa Taparra

  • August 22, 2025

Related Content

Diffuse large B-cell lymphoma presenting as a scalp tumor with skull destruction and neurological symptoms: a case report

Gastric-type endocervical adenocarcinoma with Peutz-Jeghers syndrome: a case report and literature review

Case Report: [225Ac]Ac-PSMA-617 therapy in a patient with metastatic castration-resistant prostate cancer (mCRPC) and intracranial meningioma